Parent, P.; Auclin, E.; Patrikidou, A.; Mezquita, L.; MartÃnez Chanzá, N.; Dumont, C.; Rodriguez-Vida, A.; Llacer, C.; Lozano, R.; Ratta, R.;
et al. Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma. Cancers 2023, 15, 1066.
https://doi.org/10.3390/cancers15041066
AMA Style
Parent P, Auclin E, Patrikidou A, Mezquita L, MartÃnez Chanzá N, Dumont C, Rodriguez-Vida A, Llacer C, Lozano R, Ratta R,
et al. Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma. Cancers. 2023; 15(4):1066.
https://doi.org/10.3390/cancers15041066
Chicago/Turabian Style
Parent, Pauline, Edouard Auclin, Anna Patrikidou, Laura Mezquita, Nieves MartÃnez Chanzá, Clément Dumont, Alejo Rodriguez-Vida, Casilda Llacer, Rebeca Lozano, Raffaele Ratta,
and et al. 2023. "Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma" Cancers 15, no. 4: 1066.
https://doi.org/10.3390/cancers15041066
APA Style
Parent, P., Auclin, E., Patrikidou, A., Mezquita, L., MartÃnez Chanzá, N., Dumont, C., Rodriguez-Vida, A., Llacer, C., Lozano, R., Ratta, R., Merseburger, A. S., Sternberg, C. N., Baciarello, G., Colomba, E., Fuerea, A., Besse, B., Loriot, Y., & Lavaud, P.
(2023). Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma. Cancers, 15(4), 1066.
https://doi.org/10.3390/cancers15041066
